FDA approves new drugs to treat MRSA

The first of the new antibiotics is called Dalvance. This is an intravenous drug that can treat skin and soft tissue infections. Dalvance was approved by the U.S. Food and Drug Administration (FDA) towards the end of May 2014. Continue reading →